AI assistant
Elevance Health, Inc. — Director's Dealing 2018
Mar 5, 2018
29933_dirs_2018-03-05_93425f8c-5568-4a4a-94c7-52381bdf2bb5.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Anthem, Inc. (ANTM)
CIK: 0001156039
Period of Report: 2018-03-01
Reporting Person: Samitt Craig E (EVP & Chief Clinical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-03-01 | Common Stock | F | 677 | $232.04 | Disposed | 8317 | Direct |
| 2018-03-01 | Common Stock | A | 2694 | — | Acquired | 11011 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-03-01 | Employee Stock Option (Right to Buy) | $232.04 | A | 11354 | Acquired | 2028-03-01 | Common Stock (11354) | Direct |
Footnotes
F1: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
F2: Represents restricted share units. Restrictions lapse as follows: 898 shares each on 3/1/2019, 3/1/2020 and 3/1/2021.
F3: The option represents a right to purchase a total of 11,354 shares, and is exercisable in six semi-annual installments, with four installments of 1,892 shares each and two installments of 1,893 shares each, beginning on September 1, 2018, which is the six-month anniversary of the option grant date.